1 citations
,
May 2021 in “InterConf” This publication discusses the potential mechanisms behind telogen alopecia as a dermatological manifestation of post-COVID-19 syndrome and reports no new clinical results.
25 citations
,
December 2021 in “Journal of Medical Virology” This systematic review reports that acute telogen effluvium may occur as a stress-induced hair loss following COVID-19 recovery, with most patients experiencing hair regrowth over time.
April 2023 in “Clinical dermatology review” This study found that 72% of patients who recovered from COVID-19 during the second wave reported experiencing significant hair loss, characteristic of telogen effluvium.
58 citations
,
November 2020 in “International Journal of Dermatology” COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.
July 2023 in “Zenodo (CERN European Organization for Nuclear Research)” In this review, researchers reported that post-COVID-19 syndrome may lead to significant sequelae like hair loss, potentially due to acute telogen effluvium, affecting around 20% of patients and impacting their quality of life, though specific studies on this relationship are lacking.